Sentiment for Fluidigm Corp (NASDAQ:FLDM)
Fluidigm Corp (NASDAQ:FLDM) institutional sentiment increased to 2.26 in Q4 2018. Its up 0.82, from 1.44 in 2018Q3. The ratio improved, as 61 funds started new and increased positions, while 27 sold and decreased their holdings in Fluidigm Corp. The funds in our partner’s database now hold: 42.55 million shares, up from 33.80 million shares in 2018Q3. Also, the number of funds holding Fluidigm Corp in their top 10 positions increased from 1 to 3 for an increase of 2. Sold All: 9 Reduced: 18 Increased: 30 New Position: 31.
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research. The company has market cap of $946.53 million. It offers preparatory instruments, such as access array system, juno system, and callisto system; analytical instruments comprising biomark HD and EP1 systems; integrated fluidic circuits consisting of access array, juno genotyping, dynamic array, digital array, flex six, and callisto IFCs; and assays and reagents, including delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. It currently has negative earnings. The firm also provides C1 single-cell systems, polaris systems, C1 IFCs, polaris IFCs, helios/CyTOF 2 systems, maxpar reagents, imaging mass cytometer instruments and reagents, and laser ablation modules.
The stock decreased 1.16% or $0.16 during the last trading session, reaching $13.65. About 1.76M shares traded or 96.14% up from the average. Fluidigm Corporation (NASDAQ:FLDM) has risen 69.20% since March 17, 2018 and is uptrending. It has outperformed by 64.83% the S&P500.
Analysts await Fluidigm Corporation (NASDAQ:FLDM) to report earnings on May, 2. They expect $-0.18 earnings per share, up 14.29 % or $0.03 from last year’s $-0.21 per share. After $-0.18 actual earnings per share reported by Fluidigm Corporation for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.
Healthcare Value Capital Llc holds 15.08% of its portfolio in Fluidigm Corporation for 450,000 shares. Pura Vida Investments Llc owns 678,596 shares or 3.64% of their US portfolio. Moreover, Perkins Capital Management Inc has 2.17% invested in the company for 324,800 shares. The New York-based Levin Capital Strategies L.P. has invested 1.82% in the stock. Endurant Capital Management Lp, a California-based fund reported 236,648 shares.
Since January 1, 0001, it had 15 insider buys, and 0 sales for $7.93 million activity.
Fluidigm Corporation (NASDAQ:FLDM) Ratings Coverage
Ratings analysis reveals 80% of Fluidigm’s analysts are positive. Out of 5 Wall Street analysts rating Fluidigm, 4 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $10 while the high is $15. The stock’s average target of $13.25 is -2.93% below today’s ($13.65) share price. FLDM was included in 6 notes of analysts from November 2, 2018. The stock of Fluidigm Corporation (NASDAQ:FLDM) has “Buy” rating given on Thursday, January 3 by Janney Capital. The rating was initiated by BTIG Research with “Buy” on Wednesday, March 13. The stock of Fluidigm Corporation (NASDAQ:FLDM) has “Overweight” rating given on Friday, November 2 by PiperJaffray. The rating was maintained by Piper Jaffray on Wednesday, March 13 with “Buy”.
More notable recent Fluidigm Corporation (NASDAQ:FLDM) news were published by: Globenewswire.com which released: “Fluidigm Announces Pricing of Public Offering of 8150000 Shares of Common Stock – GlobeNewswire” on December 12, 2018, also Seekingalpha.com with their article: “Fluidigm Corporation 2018 Q4 – Results – Earnings Call Slides – Seeking Alpha” published on March 12, 2019, Globenewswire.com published: “Detailed Research: Economic Perspectives on Exxon Mobil, Loxo Oncology, Fluidigm, LHC Group, Ebix, and Omega Flex â€” What Drives Growth in Today’s Competitive Landscape – GlobeNewswire” on February 19, 2019. More interesting news about Fluidigm Corporation (NASDAQ:FLDM) were released by: Globenewswire.com and their article: “Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results – GlobeNewswire” published on February 07, 2019 as well as Seekingalpha.com‘s news article titled: “Fluidigm teams up with Indica Labs in mass cytometry imaging analysis – Seeking Alpha” with publication date: February 07, 2019.